| 中文名称 | 1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride |
| 英文名称 | 1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride |
| CAS号 | 79547-78-7 |
| 分子式 | C26H30ClFN2O2 |
| 分子量 | 456.99 |
| EINECS号 | 209-062-5 |
| 溶解度 | DMSO:~10 mg/mL |
| 形态 | 固体 |
| 颜色 | 白色 |
| 危险品标志 | Xi |
| 危险类别码 | 36/37/38 |
| 安全说明 | 26-36 |
| WGK Germany | 3 |
| 海关编码 | 2933399090 |
|
H 1 Receptor
|
NTR2 17 nM (Ki) |
Levocabastine (0.25 mg/kg; i.p.; twice a day for five successive days; guinea-pigs) inhibits the virus-induced airway hyperresponsiveness, suppresses the influx of broncho-alveolar cells and increase in albumin content, and corrects the reduced chemiluminescence production by broncho-alveolar cells in response to zymosan.
In mice that receivedβ-LT, Levocabastine (0.05 mg/kg; i.p.) blocks the anxiolytic effect of β-LT and the number of head-dips decreased.